1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 14 MARCH 2016

CNS Drug News 14 MARCH 2016

  • March 2016
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - CNS Breakthroughs Slowing Despite Increasing Demand
Industry Brief - Zambon Launches Xadago In Italy For Patients With Parkinson's Disease
Industry Brief - Lilly Reports Primary Endpoint Change In Solanezumab Phase III AD Study
Industry Trend Analysis - Defensive Moves Cannot Forestall Copaxone's Generic Losses For Long
Industry Brief - Opexa Initiates Restructuring To Focus Use Of Resources
Industry Trend Analysis - Narrowing Trials Reduces Expenditure But Increases Risks For Arzerra
Industry Brief - FDA ODD For Biohaven's BHV-0223 To Treat SCA
Industry Brief - FDA ODD For AstraZeneca's MEDI-551 To Treat NMO/NMOSD
Industry Trend Analysis - Adjunctive Benefits Targeted To Drive Rexulti Sales Growth
Industry Brief - Minerva Reports Positive Top-Line Data From MIN-202 Phase Ib MDD Trial
Industry Brief - Abilify Approved In Japan For Administration At Deltoid Muscle Site
Industry Brief - SPI Enters Research Collaboration For Bipolar Disorder
Industry Brief - FDA Accepts Egalet's Arymo NDA For Review
Industry Trend Analysis - Sublingual Delivery Focus Will Underscore AcelRx's Performance
Industry Brief - New US Approvals For Hikma
Industry Brief - Xenon/ Genentech Extend Pain Genetics Research Collaboration
Industry Brief - Specialized Therapeutics/Mundipharma Enter Sublicensing Deal For Anti-Emetic Products
Industry Brief - AstraZeneca/ProStrakan Enter Deal For Moventig In Europe
Industry Brief - Alexza Enters Non-Binding Letter Of Intent With Grupo Ferrer
Industry Brief - CNS Conferences - June 2016

Table Of Contents

CNS Drug News 14 MARCH 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Bipolar disorder (BPD)  - Market Insights, Epidemiology and Market Forecast-2023

Bipolar disorder (BPD)  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Bipolar disorder (BPD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Bipolar disorder (BPD) fo ...

Bipolar disorder (BPD)  - Epidemiology Forecast To 2023

Bipolar disorder (BPD)  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight “Bipolar disorder (BPD)  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Bipolar disorder (BPD)  in seven major markets (US, France, Germany, Italy, ...

Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.